Yang D, Sheng X, Gong L, Wu X, Tang J, Wang W
Medicine (Baltimore). 2025; 104(8):e41673.
PMID: 39993063
PMC: 11856921.
DOI: 10.1097/MD.0000000000041673.
Jimenez Londono G, Perez-Beteta J, Amo-Salas M, Honguero-Martinez A, Perez-Garcia V, Lucas Lucas C
Ann Nucl Med. 2025; .
PMID: 39948296
DOI: 10.1007/s12149-025-02021-y.
Chen Z, Wang G, Wang N, Liu J, Yao Y, Ma H
Front Immunol. 2025; 16:1492501.
PMID: 39931060
PMC: 11808144.
DOI: 10.3389/fimmu.2025.1492501.
Liu X, Qian K, Su L, Tian X, Zhao X, Wang T
Eur J Med Res. 2025; 30(1):74.
PMID: 39905556
PMC: 11792379.
DOI: 10.1186/s40001-025-02327-7.
Han Y, Xiao F, Ma Q, Zhang Z, Wang Z, Liang C
World J Surg Oncol. 2025; 23(1):18.
PMID: 39849472
PMC: 11756188.
DOI: 10.1186/s12957-025-03660-1.
Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers.
Ma J, Xu X, Huang W, Hu Y, Chen G, He J
BMC Cancer. 2025; 25(1):118.
PMID: 39844108
PMC: 11752805.
DOI: 10.1186/s12885-025-13540-2.
Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolution.
Wang Z, Yuan X, Sun K, Wu F, Liu K, Jin Y
NPJ Precis Oncol. 2025; 9(1):14.
PMID: 39809905
PMC: 11733135.
DOI: 10.1038/s41698-024-00786-5.
When multiple primary lung cancers express the same rare mutation: a case report.
Han Y, Geng Y, Sui Q, Liu Y, Xie S, Gao M
Front Oncol. 2024; 14:1475193.
PMID: 39605888
PMC: 11598936.
DOI: 10.3389/fonc.2024.1475193.
Germline alteration analysis reveals EPHB4R91H mutation as a key player in multiple primary lung tumors.
Li J, Li Y, Wang X, Zhou Z, Li X, Yue S
Carcinogenesis. 2024; 46(1).
PMID: 39574310
PMC: 11886828.
DOI: 10.1093/carcin/bgae074.
Diagnosis and management of multiple primary lung cancer.
Dong H, Tian Y, Xin S, Jiang S, Guo Y, Wan Z
Front Oncol. 2024; 14:1392969.
PMID: 39411141
PMC: 11473257.
DOI: 10.3389/fonc.2024.1392969.
Identification of the Prognostic Factors for Synchronous Multiple Primary Lung Cancer Treated With Staged Bilateral Surgery.
Zhang H, Liu Q, Chen L, Song L, Mao F, Zhou W
Clin Respir J. 2024; 18(10):e70017.
PMID: 39396926
PMC: 11471348.
DOI: 10.1111/crj.70017.
The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer affect tumor stem-like property by Wnt/β-catenin pathway.
Liu Y, Fang L, Wang Y, Fan T, Wang L, Xiao C
Cell Death Dis. 2024; 15(10):738.
PMID: 39389944
PMC: 11467305.
DOI: 10.1038/s41419-024-07129-z.
Super multiple primary lung cancers harbor high-frequency BRAF and low-frequency EGFR mutations in the MAPK pathway.
Li H, Huang Z, Guo C, Wang Y, Li B, Wang S
NPJ Precis Oncol. 2024; 8(1):229.
PMID: 39384982
PMC: 11464572.
DOI: 10.1038/s41698-024-00726-3.
A retrospective analysis of simultaneous bilateral uniportal thoracoscopic surgeries for multiple primary bilateral pulmonary nodules.
Zhou J, Song X, Huang B, Zhang X, Shao J, Li L
J Cardiothorac Surg. 2024; 19(1):566.
PMID: 39354609
PMC: 11443620.
DOI: 10.1186/s13019-024-03051-9.
Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study.
Sonoda D, Maruyama R, Kondo Y, Naito M, Mikubo M, Shiomi K
Surg Today. 2024; .
PMID: 39331121
DOI: 10.1007/s00595-024-02938-3.
Prognostic factors after radical local therapy for oligo-recurrence of non-small cell lung cancer.
Sonoda D, Kondo Y, Maruyama R, Naito M, Mikubo M, Shiomi K
Gen Thorac Cardiovasc Surg. 2024; .
PMID: 39313740
DOI: 10.1007/s11748-024-02084-0.
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages.
Zhao Y, Gao J, Wang J, Fan F, Cheng C, Qian D
Nat Commun. 2024; 15(1):7928.
PMID: 39256403
PMC: 11387495.
DOI: 10.1038/s41467-024-52139-2.
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Morita M, Ono A, Sekikawa M, Doshita K, Miura K, Kodama H
Cancer Rep (Hoboken). 2024; 7(9):e70004.
PMID: 39245880
PMC: 11381551.
DOI: 10.1002/cnr2.70004.
Immunogenomic features of radiologically distinctive nodules in multiple primary lung cancer.
Chen M, Yang H, Dong Z, Li L, Li X, Luo H
Cancer Immunol Immunother. 2024; 73(11):217.
PMID: 39235522
PMC: 11377372.
DOI: 10.1007/s00262-024-03807-1.
Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors.
Choi E, Hua Y, Su C, Wu J, Neal J, Leung A
JNCI Cancer Spectr. 2024; 8(5).
PMID: 39186009
PMC: 11410193.
DOI: 10.1093/jncics/pkae072.